A phase II study of lenalidomide alone in relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndromes with chromosome 5 abnormalities (Q33919884)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II study of lenalidomide alone in relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndromes with chromosome 5 abnormalities |
scientific article |
Statements
1 reference
A phase II study of lenalidomide alone in relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndromes with chromosome 5 abnormalities (English)
1 reference
Hagop Kantarjian
1 reference
Stefan Faderl
1 reference
Zeev Estrov
1 reference
Jorge Cortes
1 reference
Farhad Ravandi
1 reference
Gautam Borthakur
1 reference
Yiming Chen
1 reference
Kristy Rey
1 reference
10 May 2012
1 reference
1 reference
12
1 reference
341-344
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference